Myrexis, Inc. (MYRX)

[surf1944]

4:18PM Myriad Pharma reports Q2 ($0.60) vs. ($0.71) in the prior year's Q4; co reported no revs vs. $0.4 mln in the prior year's quarter (MYRX) 4.97 +0.26 : Co said, "We expect our research and development expenses will increase over the next several years as we conduct additional advanced clinical trials to support the development of our potential drug candidates currently in clinical development, including MPC-4326, Azixa, and MPC-3100 and the possible advancement of certain pre-clinical drug candidates into clinical development."